Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf Mounjaro's appetite suppression seems to be fading, you are not imagining it. The effect on hunger can genuinely feel less sharp after the first few weeks or after a dose has been stable for a while — and there are clear, physiological reasons for that. This page explains what is happening, what tends to make it worse, and when it is worth talking to your prescriber. Mounjaro (tirzepatide) is a prescription-only medicine; any changes to your treatment plan need to go through a clinician, not a forum thread.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and the mechanism is fairly straightforward. When you begin tirzepatide or move to a higher dose, your body is encountering a new level of GIP and GLP-1 receptor stimulation. Gastric emptying slows, fullness signals increase, and for many people the reduction in hunger is striking. After several weeks at the same dose, some of that novelty fades as your system reaches a new equilibrium. Physiologists call this adaptive tolerance, your body is not rejecting the medicine, it is settling into it.
A misconception worth putting to rest: many people assume that if appetite suppression softens, the medicine is failing and weight loss will stall. That is not automatically true. Tirzepatide also acts on metabolic pathways beyond simple appetite, and data from the SURMOUNT-1 trial (published in the New England Journal of Medicine) showed meaningful, sustained weight reduction across 72 weeks, a period far longer than the initial appetite spike. The hunger effect and the metabolic effect are not the same thing.
That said, if the change feels significant rather than mild, it is worth paying attention rather than dismissing it. The way tirzepatide's appetite suppression works in practice varies between individuals, and your prescriber is the right person to assess whether what you are experiencing is within the expected range.
Several things can blunt how noticeable hunger control feels, and most of them are fixable. Food choices matter more than people expect. Highly processed foods (refined carbohydrates in particular) are digested quickly and bypass the slower gastric-emptying effect that makes tirzepatide's appetite suppression feel most pronounced. If your diet has drifted back toward the foods you were eating before treatment, you may experience that shift as the medicine wearing off when the more accurate description is that you have changed the conditions under which it works. The dietary patterns that complement Mounjaro are worth revisiting if appetite feels harder to manage.
Hydration and sleep are also genuinely relevant. Mild dehydration mimics hunger, and poor sleep raises ghrelin (the hormone that drives appetite), so a run of bad nights can make hunger feel like it has returned in force regardless of what your pen is doing. Stress has a similar effect through cortisol. None of this is about willpower; it is biology working against the medicine.
Timing within the weekly injection cycle can also create a pattern: appetite suppression is typically strongest in the two or three days after an injection and slightly weaker toward the end of the week as blood levels begin to fall. If you notice hunger reliably spiking on days six and seven, that is the pharmacokinetic profile of the drug rather than the medicine losing efficacy overall. Keeping a brief diary can help you (and your prescriber) tell the difference.
There is a difference between appetite suppression that feels a little less dramatic than it did in week two (expected) and appetite that has returned to near-baseline levels, with weight loss stalling for a month or more (worth a conversation). The latter is one of the scenarios a prescriber considers when reviewing whether a dose increase is appropriate, whether your injection technique needs checking, or whether something else is affecting how the medicine is absorbed.
The complete absence of appetite suppression on Mounjaro is a distinct question from suppression that has softened, but both are legitimate reasons to speak to the person managing your prescription. Injection technique is worth mentioning specifically: injecting into scar tissue or consistently into the same small area can reduce absorption, and rotating sites (abdomen, thigh, upper arm) helps maintain consistent blood levels. The NHS tirzepatide medicines page covers this alongside other practical guidance on using the pen correctly.
If you are a nume patient and something feels off, the quickest route is through our aftercare, available seven days a week. For anyone earlier in the process, understanding when appetite suppression typically begins may help calibrate what a normal trajectory looks like before assuming something has gone wrong.
The most useful thing is to separate the question of appetite from the question of weight loss progress, then address each on its own terms. If weight is still moving, even slowly, the medicine is working, a return of appetite does not cancel that. If weight loss has genuinely plateaued and appetite has returned substantially, document both and raise them at your next clinical review rather than adjusting anything yourself.
On the practical side: protein and fibre at each meal extend the fullness effect and work with the slower gastric emptying tirzepatide produces. Even foods people assume are off the table can fit a treatment-supportive diet with the right portion and pairing. Meal timing matters too, long gaps between eating tend to allow appetite to rebuild more sharply than evenly spaced meals.
The reasons Mounjaro may not be suppressing appetite as expected span injection technique, diet, sleep and dose, so it is worth working through them systematically rather than assuming the medicine itself is the problem. Our clinical team can help identify what is actually driving the change. For a broader picture of how this treatment fits into a weight management plan, the weight-loss treatment overview is a good starting point, and you can find out more about Mounjaro generally, including how it is dispensed and monitored privately. If cost is something you are weighing up, our guide to Mounjaro pricing in the UK explains what legitimate treatment includes. When you are ready to discuss your situation with a prescriber, check your eligibility for a free consultation and speak to someone who can look at the full picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.